Ipca Laboratories Limited (BOM:524494)
India
· Delayed Price · Currency is INR 1,357.55
+23.05 (1.73%)
At close: Jun 25, 2025
Ipca Laboratories Revenue
In the fiscal year ending March 31, 2025, Ipca Laboratories had annual revenue of 89.40B INR with 16.01% growth. Ipca Laboratories had revenue of 22.47B in the quarter ending March 31, 2025, with 10.46% growth.
Revenue
89.40B
Revenue Growth
+16.01%
P/S Ratio
3.86
Revenue / Employee
5.16M
Employees
17,335
Market Cap
345.49B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 89.40B | 12.34B | 16.01% |
| Mar 31, 2024 | 77.06B | 14.58B | 23.33% |
| Mar 31, 2023 | 62.48B | 4.18B | 7.16% |
| Mar 31, 2022 | 58.31B | 4.10B | 7.56% |
| Mar 31, 2021 | 54.21B | 7.71B | 16.58% |
| Mar 31, 2020 | Pro | Pro | Pro |
| Mar 31, 2019 | Pro | Pro | Pro |
| Mar 31, 2018 | Pro | Pro | Pro |
| Mar 31, 2017 | Pro | Pro | Pro |
| Mar 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Reliance Industries | 9,646.93B |
| HDFC Bank | 2,728.47B |
| Tata Consultancy Services | 2,553.24B |
| Bharti Airtel | 1,729.85B |
| ICICI Bank | 2,006.54B |
| State Bank of India | 3,429.39B |
| Infosys | 1,647.16B |
| Life Insurance Corporation of India | 8,901.58B |
Ipca Laboratories News
- 26 days ago - IPCA Laboratories shares dip over 2% after HSBC cuts target price to Rs 1,330 - Business Upturn
- 4 weeks ago - IPCA Laboratories Q4 results: Revenue jumps 10.50% YoY to Rs 2,247 crore, net profit up 14.1% YoY - Business Upturn
- 3 months ago - Ipca Laboratories to sell it Tarapur manufacturing facility for Rs 36.90 crore - Business Upturn
- 4 months ago - Ipca Laboratories shares surge over 4% on strong Q3 results, EBITDA beats estimates - Business Upturn
- 4 months ago - Ipca Laboratories Q3 FY25 Results: Revenue up 9% YoY to Rs 2,245 crore, Net Profit surges 38% YoY - Business Upturn
- 5 months ago - Former Amitabh Bacchan company, to start 100% green pharma company in Wardha - The Times of India
- 5 months ago - Pharma stocks: Glenmark up 1.57%, Glaxo gains 1.31%, Mankind Pharma declines 2.84% - Business Upturn
- 6 months ago - Stock Market Update, January 2: Lupin, Eicher Motors, IPCA Laboratories, Mahindra & Mahindra and more hit 52-week highs today - Business Upturn